| Financial Year |
March 31 2023 |
| Monetary Funds |
112,387,644.38 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
2,038,570.93 |
| Accounts Receivable |
93,050,624.75 |
| Advances to Suppliers |
9,308,421.61 |
| Other Receivables |
6,637,614.92 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
182,918,282.07 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
6,059,244.68 |
| Total Current Assets |
416,300,827.67 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
223,256,273.89 |
| Fixed Assetes |
294,527,687.91 |
| Under-construction Projects |
86,155,856.01 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
1,416,826,306.61 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
17,338,009.49 |
| Deferred Income Tax Assets |
32,216,311.93 |
| Other Non-Current Assets |
206,099,647.47 |
| Sub-Total of Non-Current Assets |
2,417,022,061.47 |
| Total Assets |
2,833,322,889.14 |
| Short-Term Loans |
33,664,937.47 |
| Trading Financial liabilities |
-- |
| Notes Payable |
42,447,399.56 |
| Accounts Payable |
99,840,711.50 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
13,259,967.80 |
| Taxes Payable |
21,865,274.84 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
36,847,044.98 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
489,893.49 |
| Other Current Liabilities |
7,849,518.58 |
| Sub-Total of Current Liabilities |
317,344,631.37 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
17,017,040.43 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
23,390,123.07 |
| Total Liabilities |
340,734,754.44 |
| Paid-In Capital(Or Share Stock) |
401,000,000.00 |
| Capital Surplus |
337,607,257.81 |
| Surplus Reserve |
167,854,543.64 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,091,443,401.91 |
| Minority Stockholder's Interest |
398,837,944.62 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,093,750,190.08 |
| Owner's Equity（Stockholder's Equity） |
2,492,588,134.70 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,833,322,889.14 |
